MedTrace Logo

Effectiveness of a Four-level Chinese Emergency Triage Scale in Mainland China

NCT03926234 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30687

Last updated 2021-06-18

No results posted yet for this study

Summary

Inter-rater reliability between experts and triage nurses was assessed in 484 emergency patients. The criterion-related validity was evaluated in other 30687 emergency patients, based on emergency department (ED) mortality, the length of stay in ED, the number of discharge, and hospitalization (intensive care/general ward).

Conditions

  • Emergencies
  • Triage

Interventions

OTHER

Four-level Chinese Emergency triage scale

a four-level category system, i.e. life-threatening (Level I), emergent (Level II), urgent (Level III) and semi-urgent (Level IV) . This system contains critical indicators (cardiac arrest, shock, and apnea), high risk indicators (ACS and DKA), single objective indicators (SBP, RR, HR, and SpO2) and MEWS (synthesis indicator). According to patients' health care problems, patients are rated by nurses into one of the four mentioned levels.

Sponsors & Collaborators

  • Beijing Chao Yang Hospital

    collaborator OTHER

  • Tongji Hospital

    collaborator OTHER

  • Henan Provincial People's Hospital

    collaborator OTHER

  • Second Affiliated Hospital of Chongqing Mecical University

    collaborator UNKNOWN

  • First People's Hospital of Hangzhou

    collaborator OTHER

  • Second People's Hospital of Hangzhou

    collaborator UNKNOWN

  • Changxing People's Hospital

    collaborator OTHER

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-12-31
Completion
2020-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03926234 on ClinicalTrials.gov